WPW
REGN icon

Waldron Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Waldron Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-288
Closed -$205K – 399
2024
Q4 		$205K Sell
288
-78
-21% -$65.5K 0.01% 399
2024
Q3 		$385K Buy
366
+4
+1% +$4.45K 0.02% 289
2024
Q2 		$380K Sell
362
-7
-2% -$6.79K 0.02% 275
2024
Q1 		$355K Buy
369
+10
+3% +$9.51K 0.02% 283
2023
Q4 		$315K Buy
359
+61
+20% +$50.2K 0.02% 300
2023
Q3 		$245K Buy
298
+4
+1% +$3.14K 0.01% 320
2023
Q2 		$211K Sell
294
-25
-8% -$19.3K 0.01% 350
2023
Q1 		$262K Buy
+319
New +$241K 0.01% 345
2017
Q2 		– Sell
-652
Closed -$240K – 189
2017
Q1 		$240K Sell
652
-222
-25% -$82.3K 0.06% 186
2016
Q4 		$320K Buy
874
+18
+2% +$6.84K 0.11% 86
2016
Q3 		$344K Buy
856
+18
+2% +$7.22K 0.12% 80
2016
Q2 		$292K Sell
838
-8
-0.9% -$3.08K 0.11% 105
2016
Q1 		$304K Buy
846
+11
+1% +$4.53K 0.11% 90
2015
Q4 		$453K Buy
835
+13
+2% +$7.04K 0.17% 71
2015
Q3 		$382K Buy
822
+57
+7% +$30.6K 0.16% 60
2015
Q2 		$390K Buy
765
+47
+7% +$22.9K 0.15% 55
2015
Q1 		$324K Buy
718
+213
+42% +$90.3K 0.13% 62
2014
Q4 		$207K Buy
+505
New +$199K 0.09% 119

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Waldron Private Wealth's REGN Position: Q1 2025 in Review

Waldron Private Wealth sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 288 shares — an estimated $205K sold.

Waldron Private Wealth first reported a position in REGN in Q4 2014 and held it in 18 quarters. The position peaked at $453K in Q4 2015. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Waldron Private Wealth reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Waldron Private Wealth sold 288 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $205K.
  • Waldron Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 18 quarters.
  • Waldron Private Wealth's Regeneron Pharmaceuticals position peaked at $453K in Q4 2015.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Waldron Private Wealth's 13F filing for Q1 2025, filed 8 May 2025.